Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs.

Enomoto, Hiroko; Love, Lydia; Madsen, Melanie; Wallace, Amber; Messenger, Kristen M

Enomoto, Hiroko; Love, Lydia; Madsen, Melanie; Wallace, Amber; Messenger, Kristen M.

Afiliación

Enomoto H; Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, USA.
Love L; Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
Madsen M; Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
Wallace A; Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA.
Messenger KM; Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, USA.

J Vet Pharmacol Ther ; 45(4): 358-365, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35445748

Asunto(s)

Buprenorfina; Administración Intravenosa/veterinaria; Administración a través de la Mucosa; Administración Oral; Analgésicos; Animales; Disponibilidad Biológica; Buprenorfina/farmacocinética; Estudios Cruzados; Perros; Masculino

Palabras clave

Simbadol™; buprenorphine; dog; intranasal; oral transmucosal; pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Buprenorfina Tipo de estudio: Prognostic_studies Idioma: En Revista: J Vet Pharmacol Ther Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google